Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1968 1
1969 2
1970 3
1971 3
1972 2
1973 6
1974 5
1975 10
1976 8
1977 8
1978 10
1979 12
1980 7
1981 23
1982 24
1983 20
1984 29
1985 43
1986 40
1987 54
1988 46
1989 74
1990 67
1991 74
1992 62
1993 73
1994 100
1995 98
1996 109
1997 107
1998 106
1999 134
2000 109
2001 128
2002 132
2003 145
2004 141
2005 132
2006 152
2007 167
2008 227
2009 189
2010 200
2011 239
2012 276
2013 289
2014 285
2015 315
2016 303
2017 355
2018 405
2019 383
2020 466
2021 474
2022 443
2023 429
2024 140

Text availability

Article attribute

Article type

Publication date

Search Results

6,963 results

Results by year

Filters applied: . Clear all
Page 1
Primary sclerosing cholangitis - a comprehensive review.
Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Karlsen TH, et al. J Hepatol. 2017 Dec;67(6):1298-1323. doi: 10.1016/j.jhep.2017.07.022. Epub 2017 Aug 10. J Hepatol. 2017. PMID: 28802875 Free article. Review.
Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressive liver disease. ...
Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressive liver disea …
Primary sclerosing cholangitis.
Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Dyson JK, et al. Lancet. 2018 Jun 23;391(10139):2547-2559. doi: 10.1016/S0140-6736(18)30300-3. Epub 2018 Feb 13. Lancet. 2018. PMID: 29452711 Review.
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. ...Patients might be asymptomatic at presentation or might have pruritus, fatigue, right upper quadrant …
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepatic stricturing …
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, et al. J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Epub 2017 Apr 18. J Hepatol. 2017. PMID: 28427765
Primary biliary cholangitis (PBC) is a chronic inflammatory autoimmune cholestatic liver disease, which when untreated will culminate in end-stage biliary cirrhosis. ...
Primary biliary cholangitis (PBC) is a chronic inflammatory autoimmune cholestatic liver disease, which when untreated will culminate …
Recent Advances in the Management of Primary Sclerosing Cholangitis.
Assis DN, Bowlus CL. Assis DN, et al. Clin Gastroenterol Hepatol. 2023 Jul;21(8):2065-2075. doi: 10.1016/j.cgh.2023.04.004. Epub 2023 Apr 19. Clin Gastroenterol Hepatol. 2023. PMID: 37084929 Free article. Review.
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by fibroinflammatory damage to the biliary tree, typically in the setting of inflammatory bowel disease, with an increased risk of liver failure and cholangiocarcinoma. ...
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by fibroinflammatory damage to the biliary …
Conventional vs Short Duration of Antibiotics in Patients With Moderate or Severe Cholangitis: Noninferiority Randomized Trial.
Srinu D, Shah J, Jena A, Jearth V, Singh AK, Mandavdhare HS, Sharma V, Irrinki S, Sakaray YR, Gupta R, Gautam V, Rana S, Dutta U. Srinu D, et al. Am J Gastroenterol. 2024 Jan 1;119(1):176-182. doi: 10.14309/ajg.0000000000002499. Epub 2023 Sep 21. Am J Gastroenterol. 2024. PMID: 37732816 Clinical Trial.
INTRODUCTION: Successful biliary drainage and antibiotics are the mainstays of therapy in management of patients with acute cholangitis. However, the duration of antibiotic therapy after successful biliary drainage has not been prospectively evaluated. ...DISCUSSION: Short …
INTRODUCTION: Successful biliary drainage and antibiotics are the mainstays of therapy in management of patients with acute cholangitis …
Primary sclerosing cholangitis.
Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Hirschfield GM, et al. Lancet. 2013 Nov 9;382(9904):1587-99. doi: 10.1016/S0140-6736(13)60096-3. Epub 2013 Jun 28. Lancet. 2013. PMID: 23810223 Review.
Primary sclerosing cholangitis is the classic hepatobiliary manifestation of inflammatory bowel disease and is generally chronic and progressive. ...Treatment of primary sclerosing cholangitis is confined to supportive measures, but advances in pathobiology suggest …
Primary sclerosing cholangitis is the classic hepatobiliary manifestation of inflammatory bowel disease and is generally chronic and …
Portal biliopathy.
Chattopadhyay S, Nundy S. Chattopadhyay S, et al. World J Gastroenterol. 2012 Nov 21;18(43):6177-82. doi: 10.3748/wjg.v18.i43.6177. World J Gastroenterol. 2012. PMID: 23180936 Free PMC article. Review.
There is a role for endoscopic therapy in patients with bile duct stones, cholangitis or when portosystemic shunt surgery is not feasible....
There is a role for endoscopic therapy in patients with bile duct stones, cholangitis or when portosystemic shunt surgery is not feas …
Immunoglobulin G4-related sclerosing cholangitis.
Goodchild G, Pereira SP, Webster G. Goodchild G, et al. Korean J Intern Med. 2018 Sep;33(5):841-850. doi: 10.3904/kjim.2018.018. Epub 2018 Jul 27. Korean J Intern Med. 2018. PMID: 30045615 Free PMC article. Review.
Immunoglobulin G4-related disease (IgG4-RD) is a systemic fibroinflammatory condition of which IgG4-related sclerosing cholangitis (IgG4-SC) is the biliary manifestation. In this review, we provide an overview of IgG4-RD, with a focus on the biliary manifestations. In part …
Immunoglobulin G4-related disease (IgG4-RD) is a systemic fibroinflammatory condition of which IgG4-related sclerosing cholangitis (I …
Prognostic modeling in biliary diseases.
Ciobanu C, Russo MW. Ciobanu C, et al. Curr Opin Gastroenterol. 2023 Mar 1;39(2):89-94. doi: 10.1097/MOG.0000000000000911. Epub 2023 Jan 3. Curr Opin Gastroenterol. 2023. PMID: 36821456 Review.
PURPOSE OF REVIEW: To discuss the prognostic models for the cholestatic diseases focusing on primary sclerosing cholangitis and primary biliary cholangitis. RECENT FINDINGS: Noninvasive prognostic models that outperform alkaline phosphatase and Mayo Risk Score have …
PURPOSE OF REVIEW: To discuss the prognostic models for the cholestatic diseases focusing on primary sclerosing cholangitis and prima …
Acute cholangitis: current concepts.
Lan Cheong Wah D, Christophi C, Muralidharan V. Lan Cheong Wah D, et al. ANZ J Surg. 2017 Jul;87(7-8):554-559. doi: 10.1111/ans.13981. Epub 2017 Mar 24. ANZ J Surg. 2017. PMID: 28337833 Review.
BACKGROUND: Acute cholangitis, also known as ascending cholangitis, is a life-threatening systemic condition that results from a biliary tree infection and obstruction. Severe acute cholangitis was reported to have a mortality rate between 11 and 27% in the 1 …
BACKGROUND: Acute cholangitis, also known as ascending cholangitis, is a life-threatening systemic condition that results from …
6,963 results